Literature DB >> 9075192

Effect of radiotherapy and chemotherapy on composition of tumor membrane phospholipids.

J C Street1, J A Koutcher.   

Abstract

Phospholipid extracts were made of a murine mammary adenocarcinoma implanted in the dorsum of the foot of C3H/He mice before and 96 h after 17 Gy irradiation or 150 mg/kg cyclophosphamide. Extracts of untreated tumors, which had grown for a further 96 h, were also studied. Although previous studies have shown significant changes in the precursors and catabolites of phosphatidylcholine and phosphatidylethanolamine following therapy, 31P nuclear magnetic resonance analysis of extracts showed no changes in these membrane constituents and other observed phospholipid species. A significant decrease in 1-alkyl-2-acyl-sn-glycero-3-phosphocholine, however, was observed 96 h following cyclophosphamide treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9075192     DOI: 10.1007/s11745-997-0007-2

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  28 in total

Review 1.  Biochemistry of platelet-activating factor: a unique class of biologically active phospholipids.

Authors:  F Snyder
Journal:  Proc Soc Exp Biol Med       Date:  1989-02

2.  In-vivo 31P magnetic resonance spectroscopy for monitoring treatment response in breast cancer.

Authors:  J Glaholm; M O Leach; D J Collins; J Mansi; J C Sharp; A Madden; I E Smith; V R McCready
Journal:  Lancet       Date:  1989-06-10       Impact factor: 79.321

3.  31P-nuclear magnetic resonance analysis of interferon-induced alterations of phospholipid metabolites in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice.

Authors:  E Proietti; G Carpinelli; M Di Vito; F Belardelli; I Gresser; F Podo
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

4.  In vivo and in vitro studies of cyclophosphamide chemotherapy in a mouse mammary carcinoma by 31P NMR spectroscopy.

Authors:  J C Street; U Mahmood; C Matei; J A Koutcher
Journal:  NMR Biomed       Date:  1995-06       Impact factor: 4.044

5.  Comparison of relative changes in phosphatic metabolites and phospholipids after irradiation.

Authors:  T E Merchant; A A Alfieri; T Glonek; J A Koutcher
Journal:  Radiat Res       Date:  1995-04       Impact factor: 2.841

6.  Testing of new hypoxic cell sensitizers in vivo.

Authors:  H B Stone; M S Sinesi
Journal:  Radiat Res       Date:  1982-07       Impact factor: 2.841

7.  Therapeutic response of breast carcinoma monitored by 31P MRS in situ.

Authors:  T C Ng; S Grundfest; S Vijayakumar; N J Baldwin; A W Majors; I Karalis; T F Meaney; K H Shin; F J Thomas; R Tubbs
Journal:  Magn Reson Med       Date:  1989-04       Impact factor: 4.668

8.  Influence of hormono- and/or chemotherapy on the MXT mouse mammary tumor as monitored by 31P MRS.

Authors:  C Scheiber; R Kiss; Y De Launoit; P Sijens; J Frühling
Journal:  Eur J Cancer       Date:  1990-03       Impact factor: 9.162

9.  Chemotherapy-induced changes in the energetics of human breast cancer cells; 31P- and 13C-NMR studies.

Authors:  M Neeman; H Eldar; E Rushkin; H Degani
Journal:  Biochim Biophys Acta       Date:  1990-05-02

10.  Activation of protein kinase C by naturally occurring ether-linked diglycerides.

Authors:  D A Ford; R Miyake; P E Glaser; R W Gross
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

View more
  1 in total

1.  Conserved molecular mechanisms underlying the effects of small molecule xenobiotic chemotherapeutics on cells.

Authors:  Hemant Sarin
Journal:  Mol Clin Oncol       Date:  2015-12-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.